BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26316070)

  • 1. Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells.
    Damiani E; Puebla-Osorio N; Gorbea E; Ullrich SE
    J Invest Dermatol; 2015 Dec; 135(12):3034-3040. PubMed ID: 26316070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor-induced expression of p21 is correlated with histone acetylation.
    Damiani E; Puebla-Osorio N; Lege BM; Liu J; Neelapu SS; Ullrich SE
    Sci Rep; 2017 Feb; 7():41959. PubMed ID: 28157211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin Modifications and Mast Cell Migration in UV-Induced Immunosuppression, an Epigenetic Piece of The Puzzle.
    van Doorn R; de Gruijl F
    J Invest Dermatol; 2015 Dec; 135(12):2911-2913. PubMed ID: 26569583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation.
    Chacón-Salinas R; Chen L; Chávez-Blanco AD; Limón-Flores AY; Ma Y; Ullrich SE
    J Leukoc Biol; 2014 Jan; 95(1):139-48. PubMed ID: 24009177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
    Damiani E; Ullrich SE
    Prog Lipid Res; 2016 Jul; 63():14-27. PubMed ID: 27073146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression.
    Walterscheid JP; Ullrich SE; Nghiem DX
    J Exp Med; 2002 Jan; 195(2):171-9. PubMed ID: 11805144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells.
    Puebla-Osorio N; Damiani E; Bover L; Ullrich SE
    Cell Death Dis; 2015 May; 6(5):e1745. PubMed ID: 25950475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human mast cells through the platelet-activating factor receptor.
    Kajiwara N; Sasaki T; Bradding P; Cruse G; Sagara H; Ohmori K; Saito H; Ra C; Okayama Y
    J Allergy Clin Immunol; 2010 May; 125(5):1137-1145.e6. PubMed ID: 20392487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression.
    Byrne SN; Limón-Flores AY; Ullrich SE
    J Immunol; 2008 Apr; 180(7):4648-55. PubMed ID: 18354188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptase-catalyzed core histone truncation: A novel epigenetic regulatory mechanism in mast cells.
    Melo FR; Wallerman O; Paivandy A; Calounova G; Gustafson AM; Sabari BR; Zabucchi G; Allis CD; Pejler G
    J Allergy Clin Immunol; 2017 Aug; 140(2):474-485. PubMed ID: 28108335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response.
    Nilsson G; Metcalfe DD; Taub DD
    Immunology; 2000 Feb; 99(2):314-9. PubMed ID: 10692052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activating factor in allergies.
    Pałgan K; Bartuzi Z
    Int J Immunopathol Pharmacol; 2015 Dec; 28(4):584-9. PubMed ID: 26486136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus.
    Zheng Y; Fan W; Zhang X; Dong E
    Epigenetics; 2016; 11(2):150-62. PubMed ID: 26890656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells.
    Zhu X; Mao X; Hurren R; Schimmer AD; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3610-7. PubMed ID: 18544619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.
    Cacan E
    J Chemother; 2017 Jun; 29(3):173-178. PubMed ID: 28102109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.